AI assistant
Savara Inc — Director's Dealing 2011
Jun 3, 2011
32709_dirs_2011-06-03_22b9e69f-ea08-4a1a-b461-ad2de8ff6c00.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADVENTRX PHARMACEUTICALS INC ([ANX])
CIK: 0001160308
Period of Report: 2011-06-02
Reporting Person: Culley Brian M (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-02 | COMMON STOCK | S | 5000 | $2.44 | Disposed | 0 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2010.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions executed by a broker-dealer at prices ranging from $2.41 to $2.48, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.